Andrea Malizia is Assistant Professor of Nuclear Measurements and Instrumentation and Radiological Safety in the Department of Biomedicine and Prevention, Faculty of Medicine and Surgery and the Faculty of Engineering at the University of Rome Tor Vergata. He completed both his B.Sc., in 2003, and M.S. (cum laude), in 2005, in Environmental Engineering at the University of Rome Tor Vergata. Dr. Malizia defended his Ph.D. in Quantum Electronics and Plasma Physics in 2010, receiving the postgraduate title in Protection against CBRNe events later in the same year and completing his second Ph.D. in Industrial Engineering at the University of Rome Tor Vergata in 2017. His field of research is related to nuclear measurements and instrumentation and to the software for simulating radiological/nuclear dispersion/diffusion.

At the University of Rome Tor Vergata, he is also the Didactical Coordinator of the International Master Courses in Protection against CBRNe events, cooperating with the most important national and international entities involved in security and safety. He also lectures in the courses of Physics, Laser Systems, Nuclear Fusion Energy, and Measurements. He is the author of more than 150 scientific papers published in international and national scientific journals and conference proceedings, 2 national patents and 5 books. He has received two awards in recognition of his research activities: “Premio Città e Sicurezza” (2007) and “Premio Sapio” (2011).

Prof. Dr. Giancarlo Cravotto

Giancarlo Cravotto became a researcher at the Department of Drug Science and Technology (University of Turin) after gaining four years of experience in the chemical and pharmaceutical industries (Chemat sas and Farmitalia-Carlo Erba Spa, respectively). He spent a year at the Techniche Universität in Berlin (Prof. P. Weyerstahl), where he worked on an organic synthesis project funded by DFG and CNR in 1992. His research activity in the domain of green organic synthesis and processing has been documented in about 480 scientific, peer-reviewed papers (H. Index 61, 16,700 citations by Web of Science; H. Index 59, 14,400 citations by Scopus; Index 66, 18,510 citations by Google Scholar), 21 patents, 42 book chapters and 7 books, and more than 500 communications to scientific meetings, including several invited plenary and keynote lectures. The extraction, purification, synthesis, and chemical modification of bioactive natural products have been the focus of his research activities. These studies have paved the way for new, non-conventional energy source-driven synthetic procedures (microwaves, ultrasound, hydrodynamic cavitation, mechanochemistry, flow chemistry, etc.) while also prompting the development of innovative hybrid reactors. He worked as a group coordinator for COST Action D32 and as a member of the Management Committee for Italy. His group has been a working partner on numerous EU projects, including “ARCADE” (7thFP), “MAPSYN” (FP7-NMP-2012), “ECOEXTRACTION” (Alcotra 2011), “US4GREENCHEM” (BBI, H2020), “COSMIC” (MSCA H2020), “RIS Challenges” - New technologies implementation in RIS regions (EIT Food BP2020), and ULTRACLEAN (Manunet III 2019). Follow recent regional/national projects: “COMPETITIVE” (AGER, Cariplo foundation), “BIOENPRO4TO” (POR FESR 14-20 Technological Platform Bioeconomy), PROMESSO (POR FESR 14-20), NUTRIBEV (Pitef grant POR FESR), and Project CRT Foundation call 2019. He collaborates with a variety of industrial partners across a number of fields, including in food processing, phytoextracts, pharmaceutics, fine chemicals, cosmetics, and biomedical polymers. He was the Director of the Department of Drug Science and Technology from 2007 to October 2018, and he is currently Full Professor of Organic Chemistry as well as the Vice Director of the department.

Marya Baig has a BSc in biomedical sciences and an MSc in bioscience from the University of Leeds. She joined MDPI in June 2020 as an Assistant Editor for Pathogens and became a Section Managing Editor for Pathogens in October 2021. She is currently the Section Managing Editor for Pathogens, a role in which she has become accustomed to the Special Issue planning process in MDPI journals.